TRIO Pharmaceuticals, Inc.
PrivateLast Round
Seed
Dec 3, 2024
Total Funding Raised
$3.1M
Momentum Score
25 /100
Company Overview
TRIO Pharmaceuticals, Inc. is a cancer immunotherapeutics company developing a proprietary platform of dual-action tumor immunity-enhancing drugs aimed at treating cancers by targeting specific antigens on cancer cells and immunosuppressor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRIO Pharmaceuticals, Inc. Comps
Public and private peers based on sector, stage, and business model.
TRIO Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 3, 2024 |
TRIO Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Myeloma Investment Fund | Seed |
| Life Science Angels | Seed |
TRIO Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TRIO Pharmaceuticals, Inc.'s valuation, stock price, and market status.
